The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy
- Pascale Fouqueray*
- , Valdis Pirags
- , Michaela Diamant
- , Guntram Schernthaner
- , Harold E. Lebovitz
- , Silvio E. Inzucchi
- , Clifford J. Bailey
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
73
Link opens in a new tab
Citations
(SciVal)
44
Downloads
(Pure)